Professor Mark Turner BSc, MBChB (Hons), PhD, DRCOG, MRCP(UK), MRCPCH, FFPM(Hon)
- Neonatal Care
- BSc, MBChB (Hons), PhD, DRCOG, MRCP(UK), MRCPCH, FFPM(Hon)
- Membership of professional bodies:
- Royal College of Paediatrics and Child Health, European Society of Developmental Perinatal and Paediatric Pharmacology
- Practices at:
- Liverpool Women's NHS Foundation Trust
- Current posts:
- Senior Lecturer in Neonatal Medicine (University of Liverpool); Director of Research and Development, Liverpool Women’s NHS Foundation Trust; Associate Director of NIHR Medicines for Children Research Network (European Affairs); Chair, NIHR MCRN Clinical Studies Group in Neonatology; Chair, NICE Guideline Development Group: Antibiotics for the prevention and treatment of early onset neonatal bacterial infection; Co-Scientific Co-ordinator, Global Research in Paediatrics (FP7 Network of Excellence to harmonise training in paediatric clinical pharmacology and conduct of clinical trials in children).
- Special clinical interests:
- Prematurity and Drug therapy
- Mark Turner trained in medicine at St. Andrews and Manchester. He trained in Paediatrics in the North West of England with specialist training in Neonatal Medicine in Manchester and Liverpool.
Newborn babies are a very vulnerable group who need personalised care that is adapted to the needs of parents and the wider family, including communication and unit routines as well as up-to-date medicines and technology. Sadly, society has neglected the needs of newborn babies when medicines have been developed and my research aims to fill some of these gaps.Professor Mark Turner